Chelidonium majus is not hepatotoxic in Wistar rats, in a 4 weeks feeding experiment

Journal of Ethnopharmacology

Volumn 126, Issue 3, 2009, Pages 518-524

  Mazzanti, Gabriela ^a   Di Sotto, Antonella ^a   Franchitto, Antonio ^a   Mammola, Caterina Loredana ^a   Mariani, Paola ^a   Mastrangelo, Sabina ^a   Menniti Ippolito, Francesca ^b   Vitalone, Annabella ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Chelidonium majus; Greater celandine; Hepatotoxicity; Liver function

Indexed keywords

ALKALOID DERIVATIVE; CHELIDONIUM EXTRACT; GLUTATHIONE; MALONALDEHYDE; PARACETAMOL; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHEMICAL ANALYSIS; CONTROLLED STUDY; DOSE LIVER FUNCTION RELATION; DRUG BLOOD LEVEL; DRUG TISSUE LEVEL; ENZYME ACTIVITY; EXPERIMENTAL DESIGN; FEEDING; FOOD INTAKE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIVER TOXICITY; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; SINGLE DRUG DOSE; WISTAR RAT;

ADMINISTRATION, ORAL; ANIMALS; CHELIDONIUM; GLUTATHIONE; IMMUNOHISTOCHEMISTRY; LIVER; MALE; MALONDIALDEHYDE; PLANT EXTRACTS; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE;

ANIMALIA; CHELIDONIUM; CHELIDONIUM MAJUS; PAPAVERACEAE; RATTUS NORVEGICUS;

EID: 70449658851     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2009.09.004     Document Type: Article

References (37)

1. Australian Government, 2005. CMEC-Complementary Medicines Evaluation Committee. Item 10.3, 14.
2. Barnes J., Anderson L.A., and Phillipson J.D. Celandine, Greater: In Herbal Medicines. 3rd Ed. (2007), Pharmaceutical Press, London pp. 136-145
3. Barreto M.C., Pinto R.E., Arrabaça J.D., and Pavão M.L. Inhibition of mouse liver respiration by Chelidonium majus isoquinoline alkaloids. Toxicology Letter 146 (2003) 37-47
4. Becci P.J., Schwartz H., Barnes H.H., and Southard G.L. Short-term toxicity studies of sanguinarine and of two alkaloid extracts of Sanguinaria canadensis L. Journal of Toxicology and Environmental Health 20 (1987) 199-208
5. Benigni R., Capra C., and Cattorini P.F. Chelidonia. In Piante medicinali: chimica farmacologia e terapia vol. 1 (1962), Inverni & Della Beffa, Milano pp. 281
6. Benninger J., Schneider H.T., Schuppan D., Kirchner T., and Hahn E.G. Acute hepatitis induced by greater celandine (Chelidonium majus). Gastroenterology 117 (1999) 1234-1237
7. Bhanwra S., Singh J., and Khosla P. Effect of Azadirachta indica (Neem) leaf aqueous extract on paracetamol-induced liver damage in rats. Indian Journal of Physiology & Pharmacology 44 (2000) 64-68
8. Biswas S.J., Bhattacharjee N., and Khuda-Bukhsh A.R. Efficacy of a plant extract (Chelidonium majus L.) in combating induced hepatocarcinogenesis in mice. Food and Chemical Toxicology 46 (2008) 1474-1487
9. Bosisio E., and Colombo M.L. Pharmacological activity of Chelidonium majus L. (Papaveraceae). Pharmacological Research 33 (1996) 127-134
10. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72 (1976) 248-254
11. Branchi I., Capone F., Vitalone A., Madia F., Cantucci D., Alleva E., and Costa L.G. Early developmental exposure to BDE 99 or Aroclor 1254 affects neurobehavioural profile: interference from the administration route. Neurotoxicology 26 (2005) 183-192
12. Choy C.S., Cheah K.P., Chiou H.Y., Li J.S., Liu Y.H., Yong S.F., Chiu W.T., Liao J.W., and Hu C.M. Induction of hepatotoxicity by sanguinarine is associated with oxidation of protein thiols and disturbance of mitochondrial respiration. Journal of Applied Toxicology 28 (2008) 945-956
13. Chung H.S., An H.J., Jeong H.J., Won J.H., Hong S.H., and Kim H.M. Water extract isolated from Chelidonium majus enhances nitric oxide and tumour necrosis factor-alpha production via nuclear factor-kappaB activation in mouse peritoneal macrophages. Journal of Pharmacy and Pharmacology 56 (2004) 129-134
14. Conti E., De Checchi G., Mencarelli R., Pinato S., and Rovere P. Lycopodium similiaplex-induced acute hepatitis: a case report. European Journal of Gastroenterology and Hepatology 20 (2008) 469-471
15. European Pharmacopoeia. Greater Celandine-Chelidonii herba. 5th Ed. vol. 2 (2005), Directorate for the Quality of Medicines of the Council of Europe, Strasbourg Cedex pp. 1690-1691
16. Gaudio E., Barbaro B., Alvaro D., Glaser S., Francis H., Ueno Y., Meininger C.J., Franchitto A., Onori P., Marzioni M., Taffetani S., Fava G., Stoica G., Venter J., Reichenbach R., De Morrow S., Summers R., and Alpini G. Vascular endothelial growth factor stimulates rat cholangiocyte proliferation via an autocrine mechanism. Gastroenterology 130 (2006) 1270-1282
17. Greving I., Meister V., Monnerjahn C., Müller K.M., and May B. Chelidonium majus: a rare reason for severe hepatotoxic reaction. Pharmacoepidemiology and Drug Safety 7 (1998) S66-99
18. Hardeman E., Van Overbeke L., Ilegems S., and Ferrante M. Acute hepatitis induced by Greater celandine (Chelidonium majus). Acta Gastro-enterologica Belgica 71 (2008) 281-282
19. Hiller K.O., Ghorbani M., and Schilcher H. Antispasmodic and relaxant activity of chelidonine, coptisine, and Chelidonium majus extracts on guinea-pig ileum. Planta Medica 64 (1998) 758-760
20. Kokosca L., Polesny Z., Rada V., Nepovim A., and Vanek T. Screening of some Siberian medicinal plants for antimicrobial activity. Journal of Ethnopharmacology 82 (2002) 51-53
21. Kosina P., Walterová D., Ulrichová J., Lichnovský V., Stiborová M., Rýdlová H., Vicar J., Krecman V., Brabec M.J., and Simánek V. Sanguinarine and chelerythrine: assessment of safety on pigs in ninety days feeding experiment. Food and Chemical Toxicology 42 (2004) 85-91
22. Kuralay F., Akarca U.S., Ozütemiz A.O., Kutay F., and Batur Y. Possible role of glutathione in prevention of acetaminophen-induced hepatotoxicity enhanced by fish oil in male Wistar rats. Journal of Toxicology and Environmental Health A 53 (1998) 223-229
23. Manna P., Sinha M., and Sil P.C. Aqueous extract of Terminalia arjuna prevents carbon tetrachloride induced hepatic and renal disorders. BMC Complementary and Alternative Medicine 6 (2006) 33
24. Mazzanti G., Di Sotto A., Franchitto A., Mastrangelo S., Pezzella M., Vitalone A., and Mammola C.L. Effects of Cimicifuga racemosa extract on liver morphology and hepatic function indices. Phytomedicine 15 (2008) 1021-1024
25. Menniti Ippolito F., Mazzanti G., Santuccio C., Moro A.P., Calapai G., Firenzuoli F., Valeri A., and Raschetti R. Surveillance of suspected adverse reactions to natural health products in Italy. Pharmacoepidemiology Drug Safety 17 (2008) 626-635
26. Miller L.G. Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions. Archives of Internal Medicine 158 20 (1998) 2200-2211
27. Moro P., Cassetti F., Giuliano G., Falce M.T., Mazzanti G., Menniti-Ippolito F., Raschetti R., and Santuccio C. Hepatitis from Greater celandine (Chelidonium majus L.): review of literature and report of a new case. Journal of Ethnopharmacology 124 (2009) 328-332
28. Niederau C., and Göpfert E. The effect of chelidonium and turmeric root extract on upper abdominal pain due to functional disorders of the biliary system. Results from a placebo-controlled double-blind study. Medizinische Klinik (Munich) 94 (1999) 425-430
29. Peskin A.V., and Winterbourn C.C. A microtiter plate assay for superoxide dismutase using a water-soluble tetrazolium salt (WST-1). Clinica Chimica Acta 293 (2000) 157-166
30. Pittler M.H., and Ernst E. Systematic review: events associated with herbal medicinal products. Alimentary Pharmacology and Therapeutics 18 (2003) 451-471
31. Ritter R., Schatton W.F.H., Gessner B., and Willems M. Clinical trial on standardized celandine extract in patients with functional epigastric complaints: results of a placebo-controlled double blind trial. Complementary Therapies in Medicine 1 (1993) 189-193
32. Saglam H., and Arar G. Cytotoxic activity and quality control determinations on Chelidonium majus. Fitoterapia 74 (2003) 127-129
33. Stickel F., Patsenker E., and Schuppan D. Herbal hepatotoxicity. Journal of Hepatology 43 (2005) 901-910
34. Stickel F., Pöschl G., Seitz H.K., Waldherr R., Hahn E.G., and Schuppan D. Acute hepatitis induced by Greater Celandine (Chelidonium majus). Scandinavian Journal of Gastroenterology 38 (2003) 565-568
35. Vahlensieck U., Hahn R., Winterhoff H., Gumbinger H.G., Nahrsted A., and Kemper F.H. The effect of Chelidonium majus herb extract on choleresis in the isolated perfused rat liver. Planta Medica 61 (1995) 267-270
36. Vitalone A., Catalani A., Chiodi V., Cinque C., Fattori V., Goldoni M., Matteucci P., Poli D., Zuena A.R., and Costa L.G. Neurobehavioral assessment of rats exposed to low doses of PCB126 and methyl mercury during development. Environmental Toxicology and Pharmacology 25 (2008) 103-113
37. Williams M.K., Dalvi S., and Dalvi R.R. Influence of 3-methylcholanthrene pretreatment on sanguinarine toxicity in mice. Veterinary and Human Toxicology 42 (2000) 196-198